Sarepta Partners Inks New Partnership with Roche

Congratulations to H+C client Sarepta Therapeutics for its newly inked partnership with Roche to develop and commercialize gene therapies outside the U.S. for Duchenne muscular dystrophy, allowing a global reach for patients living with this devastating and fatal rare disease.Read more in Endpoints. Sarepta


Join The Conversation

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow us on instagram